Randomized Phase II trial of paclitaxel and carboplatin followed by gemcitabine switch-maintenance therapy versus gemcitabine and carboplatin followed by gemcitabine continuation-maintenance therapy in previously untreated advanced non-small cell lung cancer

Randomized Phase II trial of paclitaxel and carboplatin followed by gemcitabine switch-maintenance therapy versus gemcitabine and carboplatin followed by gemcitabine continuation-maintenance therapy in previously untreated advanced non-small cell lung cancer

<p>Abstract</p> <p>Background</p> <p>In recent years, maintenance chemotherapy is increasingly being recognized as a new treatment strategy to improve the outcome of advanced non-small cell lung cancer (NSCLC). However, the optimal maintenance strategy is still controve...

Full description

Bibliographic Details
Main Authors: Minami Seigo, Kijima Takashi, Shiroyama Takayuki, Okafuji Kohei, Hirashima Tomonori, Uchida Junji, Imamura Fumio, Osaki Tadashi, Nakatani Takeshi, Ogata Yoshitaka, Yamamoto Suguru, Namba Yoshinobu, Otsuka Tomoyuki, Tachibana Isao, Komuta Kiyoshi, Kawase Ichiro
Format: Article
Language:English
Published: BMC 2013-01-01
Series:BMC Research Notes
Subjects:
Carboplatin
Gemcitabine
Paclitaxel
Switch-maintenance
Continuation-maintenance
Non-small cell lung cancer (NSCLC)
Randomized phase II
Online Access:http://www.biomedcentral.com/1756-0500/6/3

Internet

http://www.biomedcentral.com/1756-0500/6/3

Similar Items